Peptide Logic

About:

Peptide Logic is a biopharmaceutical company developing peptide-antibody conjugates for pain.

Website: https://www.peptidelogic.com/

Top Investors: National Institute on Drug Abuse (NIDA)

Description:

Peptide Logic is a biopharmaceutical company that combines the advantages of synthetic peptides and recombinant antibodies to create transformative peptide-antibody conjugates (PACs) for pain and other selected therapeutic areas. To create the peptide-based drugs of the future, Peptide Logic is building the most comprehensive and versatile peptide technology platform through in-licensing, partnerships, and internal development. It is also developing multi-product pipelines of first-in-class peptide-based drugs in pain and other selected therapeutic areas.

Total Funding Amount:

$2.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Founders:

Pierre Riviere

Number of Employees:

1-10

Last Funding Date:

2018-08-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai